PharmaShots | Incisive News in 3 Shots

Subscribe Now

NP-lll Development

Novo Nordisk to Initiate a P-lll Study of Semaglutide to Treat Alzheimer Disease

Novo Nordisk to Initiate a P-lll Study of Semaglutide to Treat Alzheimer Disease

December 17, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us